JUM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balu-Maestro, C.
Right arrow Articles by Bittman, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balu-Maestro, C.
Right arrow Articles by Bittman, O.

Journal of Ultrasound in Medicine, Vol 10, Issue 1 1-7, Copyright © 1991 by American Institute of Ultrasound in Medicine


JOURNAL ARTICLE

Ultrasonographic posttreatment follow-up of breast cancer patients

C. Balu-Maestro, J. N. Bruneton, A. Geoffray, C. Chauvel, A. Rogopoulos and O. Bittman
Service de Radiodiagnostic, Centre Antoine-Lacassagne, Nice, France.

Clinical, radiographic (mammograms), and ultrasonographic data were compared retrospectively for 171 patients to evaluate the utility of ultrasound for the follow-up of breast cancer patients treated medically or by conservative surgery. When used to follow patients treated medically by induction or exclusive chemotherapy, ultrasonography accurately quantified tumor and nodal regression. After conservative surgery, sonograms are ideal to diagnose (and sometimes to treat) early complications such as hematoma, lymphocele, and abscess. Ultrasonography was more sensitive than mammography for the detection of late complications and benign lesions, but was insufficient for the detection of recurrent disease (95.5% sensitivity for radiography vs 90% for ultrasonography). After radical surgery and breast reconstruction, ultrasonography is the only procedure required for follow-up of patients with breast implants because it can determine the size and penetration of cutaneous recurrences. The fact that 30% of patients treated by lumpectomy and irradiation ultimately develop malignant or benign abnormalities justifies systematic ultrasonography for the follow-up of treated breast cancers. All sonographically demonstrable abnormalities warrant ultrasound-guided puncture biopsy.


This article has been cited by other articles:


Home page
J Ultrasound MedHome page
J. H. Shin, B.-K. Han, Y. H. Choe, S.-J. Nam, W. Park, and Y.-H. Im
Ultrasonographic Detection of Occult Cancer in Patients After Surgical Therapy for Breast Cancer
J. Ultrasound Med., May 1, 2005; 24(5): 643 - 649.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
P. S. Wellman, E. P. Dalton, D. Krag, K. A. Kern, and R. D. Howe
Tactile Imaging of Breast Masses: First Clinical Report
Arch Surg, February 1, 2001; 136(2): 204 - 208.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Institute of Ultrasound in Medicine.